Scarica l'app Stockscreener
10.78
5.02%
-0.57
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AVXL Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$11.35
Aprire:
$11.32
Volume 24 ore:
1.63M
Relative Volume:
1.62
Capitalizzazione di mercato:
$920.79M
Reddito:
-
Utile/perdita netta:
$-43.16M
Rapporto P/E:
-19.60
EPS:
-0.55
Flusso di cassa netto:
$-29.31M
1 W Prestazione:
-1.01%
1M Prestazione:
-2.97%
6M Prestazione:
+23.91%
1 anno Prestazione:
+75.00%
Intervallo 1D:
$10.50
$11.70
Intervallo di 1 settimana:
$10.50
$11.70
Portata 52W:
$4.9301
$14.44
Anavex Life Sciences Corporation Stock (AVXL) Company Profile
Nome
Anavex Life Sciences Corporation
Settore
Industria
Telefono
844-689-3939
Indirizzo
630 5TH AVENUE, NEW YORK
Confronta AVXL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVXL
Anavex Life Sciences Corporation
|
10.78 | 969.48M | 0 | -43.16M | -29.31M | -0.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Anavex Life Sciences Corporation Stock (AVXL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-12-06 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-23 | Iniziato | Berenberg | Buy |
| 2021-09-23 | Iniziato | BTIG Research | Buy |
| 2020-12-16 | Reiterato | H.C. Wainwright | Buy |
| 2020-09-28 | Iniziato | Ladenburg Thalmann | Buy |
| 2020-02-27 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-06-18 | Iniziato | Janney | Buy |
| 2018-05-16 | Ripresa | Maxim Group | Buy |
| 2018-03-08 | Iniziato | ROTH Capital | Buy |
| 2018-02-13 | Reiterato | Maxim Group | Buy |
| 2017-09-29 | Ripresa | Noble Financial | Buy |
| 2017-02-07 | Iniziato | Noble Financial | Buy |
| 2016-03-29 | Iniziato | FBR Capital | Outperform |
Mostra tutto
Anavex Life Sciences Corporation Borsa (AVXL) Ultime notizie
Anavex Life Sciences: Fiscal Q3 Earnings Snapshot - San Francisco Chronicle
Earnings call transcript: Anavex Life Sciences Q3 2025 sees R&D drop - Investing.com UK
Anavex Life Sciences Reports Fiscal 2025 Third Quarter Financial Results and Provides Business Update - The Globe and Mail
Anavex Life Sciences Corp. Q3 Loss Increases, Misses Estimates - Nasdaq
Anavex Life Sciences Fiscal Q3 Loss Widens - MarketScreener
Anavex Life Sciences Corp. Reports Q3 Fiscal 2025 Financial Results and Webcast Announcement - Quiver Quantitative
Anavex Reports Breakthrough: Oral Alzheimer's Drug Maintains Benefits After 4 Years as Cash Position Tops $100M - Stock Titan
Anavex Life Sciences Amends Executive Employment Contracts - MSN
How high can Anavex Life Sciences Corp. stock goRSI and MACD Signal Summary with Trends - Newser
Understanding Anavex Life Sciences Corp.’s price movementSmart Trade Mapping with Entry Details - Newser
Why Anavex Life Sciences Corp. stock attracts strong analyst attentionSwing Watchlist With Tight Stop Placement - Newser
Sector ETF performance correlation with Anavex Life Sciences Corp.Stock Entry Points Based on Technicals - Newser
Historical volatility pattern of Anavex Life Sciences Corp. visualizedEquity Portfolio Outlook and Performance Summary - Newser
Real time social sentiment graph for Anavex Life Sciences Corp.Market Sentiment Tracker with Smart Alerts - Newser
What technical models suggest about Anavex Life Sciences Corp.’s comebackPrice Movement and Market Sentiment Analysis - Newser
Published on: 2025-08-10 02:07:10 - Newser
Can a trend reversal in Anavex Life Sciences Corp. lead to recoveryYearly Trend Summary and Opportunity Breakdown - Newser
Can Anavex Life Sciences Corp. recover in the next quarterROI Focused Setup Screener With Exit Markers - Newser
How Resilient Is Anavex Life Sciences Corp. Stock During Economic DownturnsFree Risk Controlled Short Term Trade Plans - Newser
Is Anavex Life Sciences Corp. stock reversal real or fakeIntraday Price Forecast Using Volume Models - Newser
Will Anavex Life Sciences Corp. outperform the marketVolume Spike Detection for Early Breakouts - Newser
Risk adjusted return profile for Anavex Life Sciences Corp. analyzedChart Signal and Short-Term Forecast Tracker - Newser
Envestnet Asset Management Inc. Sells 6,064 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
D. Boral Capital Reiterates Buy Rating for Anavex Life Sciences (NASDAQ:AVXL) - Defense World
Identifying reversal signals in Anavex Life Sciences Corp.Trend Following Ideas with Volume Confirmation - Newser
Anavex Life Sciences to Announce Fiscal 2025 Third Quarter Finan - GuruFocus
Anavex Life Sciences Corp. Schedules Third Quarter Financial Results and Conference Call for August 12, 2025 - Quiver Quantitative
Anavex Life Sciences Earnings: Latest Updates on Alzheimer's and Parkinson's Drug Development Coming August 12 - Stock Titan
Anavex Life Sciences to Announce Fiscal 2025 Third Quarter Financial Results on Tuesday, August 12, 2025 - The Manila Times
Alzheimer's Disease Disease-Modifying Therapies Markets, 2023-2025 & 2026-2030 | Key Marketed Products, Clinical Trials, Competitive Scenario and R&D Activities - GlobeNewswire Inc.
What data driven models say about Anavex Life Sciences Corp.’s futureFree Stock Market Watch With Alerts - Newser
Can Anavex Life Sciences Corp. rally from current levelsHigh Confidence Strategy with Trend Alignment - Newser
Is Anavex Life Sciences Corp. stock a growth or value playDay Trading Setup Forecast with Trend Model - Newser
What catalysts could drive Anavex Life Sciences Corp. stock higher in 2025Maximize your gains with expert trading tips - Jammu Links News
What institutional investors are buying Anavex Life Sciences Corp. stockGet real-time alerts on top-performing stocks - Jammu Links News
Should I hold or sell Anavex Life Sciences Corp. stock in 2025Get timely alerts on market movers - Jammu Links News
Is it the right time to buy Anavex Life Sciences Corp. stockMassive stock growth - Jammu Links News
What are analysts’ price targets for Anavex Life Sciences Corp. in the next 12 monthsOutstanding investment returns - Jammu Links News
Anavex Life Sciences Corporation Azioni (AVXL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.91%
3.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):